Mercer Global Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$863K Sell
42,831
-80
-0.2% -$1.44K ﹤0.01% 1941
2026
Q2
$743K Buy
42,911
+1,264
+3% +$17.3K ﹤0.01% 1979
2026
Q1
$518K Sell
41,647
-24,050
-37% -$323K ﹤0.01% 1957
2025
Q4
$828K Buy
65,697
+55,242
+528% +$632K ﹤0.01% 1561
2025
Q3
$105K Buy
+10,455
New +$93.8K ﹤0.01% 2510

Other funds holding AMRX

Mercer Global Advisors's AMRX Position: Q3 2026 in Review

Mercer Global Advisors reduced its Amneal Pharmaceuticals (AMRX) stake by 0.19% in Q3 2026, selling an estimated $1.44K and leaving 42,831 shares worth $863K. The position accounts for ﹤0.01% of the portfolio, ranked #1941.

Mercer Global Advisors first reported a position in AMRX in Q3 2025 and has held it in 5 quarters since. 334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Mercer Global Advisors held 42,831 shares of Amneal Pharmaceuticals worth $863K as of Q3 2026.
  • Mercer Global Advisors sold 80 Amneal Pharmaceuticals shares in Q3 2026, an estimated $1.44K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q3 2026, its #1941 holding.
  • Mercer Global Advisors first reported a position in Amneal Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Mercer Global Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.